| __timestamp | Takeda Pharmaceutical Company Limited | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 382096000000 | 293000 |
| Thursday, January 1, 2015 | 345927000000 | 1002000 |
| Friday, January 1, 2016 | 312303000000 | 888000 |
| Sunday, January 1, 2017 | 325441000000 | 19623000 |
| Monday, January 1, 2018 | 368298000000 | 30421000 |
| Tuesday, January 1, 2019 | 492381000000 | 34794000 |
| Wednesday, January 1, 2020 | 455833000000 | 28304000 |
| Friday, January 1, 2021 | 526087000000 | 56886000 |
| Saturday, January 1, 2022 | 633325000000 | 100894000 |
| Sunday, January 1, 2023 | 729924000000 | 159765000 |
| Monday, January 1, 2024 | 729924000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, innovation is the key to staying ahead. Takeda Pharmaceutical Company Limited, a global leader, has consistently outpaced Viridian Therapeutics, Inc. in research and development (R&D) investments over the past decade. From 2014 to 2023, Takeda's R&D expenses have surged by approximately 91%, reflecting its commitment to pioneering new treatments. In contrast, Viridian's R&D spending, while growing, remains a fraction of Takeda's, highlighting the disparity in scale and resources.
Takeda's R&D investments have grown from 38% of its 2014 levels to a staggering 73% increase by 2023. Meanwhile, Viridian, a smaller player, has seen its R&D expenses rise significantly, yet it still trails behind. This trend underscores the competitive nature of the pharmaceutical industry, where larger firms like Takeda leverage their resources to maintain a leading edge in innovation.
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and Takeda Pharmaceutical Company Limited
AbbVie Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Novartis AG vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Takeda Pharmaceutical Company Limited or Verona Pharma plc: Who Invests More in Innovation?
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.
R&D Spending Showdown: Neurocrine Biosciences, Inc. vs Viridian Therapeutics, Inc.
Bio-Techne Corporation or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioCryst Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.